70 related articles for article (PubMed ID: 15710358)
1. Molecular modes of action of cantharidin in tumor cells.
Efferth T; Rauh R; Kahl S; Tomicic M; Böchzelt H; Tome ME; Briehl MM; Bauer R; Kaina B
Biochem Pharmacol; 2005 Mar; 69(5):811-8. PubMed ID: 15710358
[TBL] [Abstract][Full Text] [Related]
2. Molecular biology of cantharidin in cancer cells.
Rauh R; Kahl S; Boechzelt H; Bauer R; Kaina B; Efferth T
Chin Med; 2007 Jul; 2():8. PubMed ID: 17610718
[TBL] [Abstract][Full Text] [Related]
3. Entomological Surveillance and Cantharidin Concentrations in
Jakovac-Strajn B; Brozić D; Tavčar-Kalcher G; Babič J; Trilar T; Vengust M
Animals (Basel); 2021 Jan; 11(1):. PubMed ID: 33477415
[TBL] [Abstract][Full Text] [Related]
4. Anticancer Attributes of Cantharidin: Involved Molecular Mechanisms and Pathways.
Naz F; Wu Y; Zhang N; Yang Z; Yu C
Molecules; 2020 Jul; 25(14):. PubMed ID: 32707651
[TBL] [Abstract][Full Text] [Related]
5. Cantharidin.
Am J Health Syst Pharm; 2023 Nov; 80(23):1686-1688. PubMed ID: 37703104
[No Abstract] [Full Text] [Related]
6. Hepatotoxic mechanism of cantharidin: insights and strategies for therapeutic intervention.
Jin D; Huang NN; Wei JX
Front Pharmacol; 2023; 14():1201404. PubMed ID: 37383714
[TBL] [Abstract][Full Text] [Related]
7. Norcantharidin down-regulates iron contents in the liver and spleen of lipopolysaccharide-treated mice.
Zheng J; Wang JJ; Ma HM; Shen MQ; Qian ZM; Bao YX
Redox Rep; 2022 Dec; 27(1):119-127. PubMed ID: 35735222
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological mechanism of mylabris in the treatment of leukemia based on bioinformatics and systematic pharmacology.
Zhan H; Bai Y; Lv Y; Zhang X; Zhang L; Deng S
Bioengineered; 2021 Dec; 12(1):3229-3239. PubMed ID: 34224300
[TBL] [Abstract][Full Text] [Related]
9. Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers.
Abadi AJ; Zarrabi A; Gholami MH; Mirzaei S; Hashemi F; Zabolian A; Entezari M; Hushmandi K; Ashrafizadeh M; Khan H; Kumar AP
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670518
[TBL] [Abstract][Full Text] [Related]
10. Antitumor potential of the protein phosphatase inhibitor, cantharidin, and selected derivatives.
Ren Y; Kinghorn AD
Bioorg Med Chem; 2021 Feb; 32():116012. PubMed ID: 33454654
[TBL] [Abstract][Full Text] [Related]
11. Cantharidin Induces Apoptosis and Promotes Differentiation of AML Cells Through Nuclear Receptor Nur77-Mediated Signaling Pathway.
Yu Z; Li L; Wang C; He H; Liu G; Ma H; Pang L; Jiang M; Lu Q; Li P; Qi H
Front Pharmacol; 2020; 11():1321. PubMed ID: 32982739
[TBL] [Abstract][Full Text] [Related]
12. NCTD elicits proapoptotic and antiglycolytic effects on colorectal cancer cells via modulation of Fam46c expression and inhibition of ERK1/2 signaling.
Zhang S; Yang Y; Hua Y; Hu C; Zhong Y
Mol Med Rep; 2020 Aug; 22(2):774-782. PubMed ID: 32468032
[TBL] [Abstract][Full Text] [Related]
13. Deciphering Biological Processes at the Tick-Host Interface Opens New Strategies for Treatment of Human Diseases.
Štibrániová I; Bartíková P; Holíková V; Kazimírová M
Front Physiol; 2019; 10():830. PubMed ID: 31333488
[TBL] [Abstract][Full Text] [Related]
14. Contribution of p38 MAPK Pathway to Norcantharidin-Induced Programmed Cell Death in Human Oral Squamous Cell Carcinoma.
Ahn CH; Hong KO; Jin B; Lee W; Jung YC; Lee H; Shin JA; Cho SD; Hong SD
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315217
[TBL] [Abstract][Full Text] [Related]
15. Beetles as Model Organisms in Physiological, Biomedical and Environmental Studies - A Review.
Adamski Z; Bufo SA; Chowański S; Falabella P; Lubawy J; Marciniak P; Pacholska-Bogalska J; Salvia R; Scrano L; Słocińska M; Spochacz M; Szymczak M; Urbański A; Walkowiak-Nowicka K; Rosiński G
Front Physiol; 2019; 10():319. PubMed ID: 30984018
[TBL] [Abstract][Full Text] [Related]
16. Roles of p38 and JNK protein kinase pathways activated by compound cantharidin capsules containing serum on proliferation inhibition and apoptosis of human gastric cancer cell line.
Sun Y; Zhang D; Mao M; Lu Y; Jiao N
Exp Ther Med; 2017 Aug; 14(2):1809-1817. PubMed ID: 28810654
[TBL] [Abstract][Full Text] [Related]
17. Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression.
Wan XY; Zhai XF; Jiang YP; Han T; Zhang QY; Xin HL
Am J Transl Res; 2017; 9(1):155-166. PubMed ID: 28123642
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic relevance of the protein phosphatase 2A in cancer.
Cunningham CE; Li S; Vizeacoumar FS; Bhanumathy KK; Lee JS; Parameswaran S; Furber L; Abuhussein O; Paul JM; McDonald M; Templeton SD; Shukla H; El Zawily AM; Boyd F; Alli N; Mousseau DD; Geyer R; Bonham K; Anderson DH; Yan J; Yu-Lee LY; Weaver BA; Uppalapati M; Ruppin E; Sablina A; Freywald A; Vizeacoumar FJ
Oncotarget; 2016 Sep; 7(38):61544-61561. PubMed ID: 27557495
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of Canthardin Sulfanilamides and Their Acid Anhydride Analogues via a Ring-Opening Reaction of Activated Aziridines and Their Associated Pharmacological Effects.
Chiang LL; Tseng IJ; Lin PY; Sheu SY; Lin CT; Hsieh YH; Lin YJ; Chen HL; Lin MH
Molecules; 2016 Jan; 21(1):100. PubMed ID: 26784163
[TBL] [Abstract][Full Text] [Related]
20. Cantharidin modulates the E2F1/MCM7-miR-106b-93/p21-PTEN signaling axis in MCF-7 breast cancer cells.
Zhang H; Yan X
Oncol Lett; 2015 Nov; 10(5):2849-2855. PubMed ID: 26722252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
